ASXBlog

PODCAST | THE IDEAS EXCHANGE

12 MAY 2022

Impact investing - delivering financial and social returns

Caroline Gurney, CEO of Future Generation  

ARTICLE | ON THE BOARD

11 MAY 2022

ASX - competing on a global scale

Kate Galpin, Listings, ASX

ARTICLE | INVESTOR UPDATE

6 MAY 2022

What drives bank stocks 

Will Riggall, Clime Investment Management 

PODCAST | MARKET UPDATE

4 MAY 2022

April Market Wrap

Graham O'Brien, ASX  

PODCAST | THE IDEAS EXCHANGE

06 MAY 2022

What drives bank stocks 

Will Riggall, Clime Investment Management

Three main factors explain the banking sector’s performance.

ARTICLE | INVESTOR UPDATE

06 MAY 2022

Five Factors that drive returns

Neil Broadbent, iShares

Understand how to use Factor-based investing through ETFs.

ARTICLE | INVESTOR UPDATE

06 MAY 2022

Green hydrogen good for climate but tough investment 

Tom King, Nanuk Asset Management

Learn why interest in green hydrogen is growing – and the risks to watch.

ARTICLE | INVESTOR UPDATE

06 MAY 2022

Understanding private debt

Andrew Lockhart, Metrics Credit Partners

Learn about the features, benefits and risks of including private debt in portfolios.

ARTICLE | INVESTOR UPDATE

06 MAY 2022

ASIC warns of investing under the ‘finfluence’

Greg Yanco,  ASIC

Investor protection laws apply online to financial influencers.

ARTICLE | INVESTOR UPDATE

06 MAY 2022

ASX Investor Day: four top investment themes not to miss

ASX asked some panellists at the upcoming event for their top idea or theme for 2022 and beyond.

IPO REVIEW | ON THE BOARD

11 MAY 2022

ASX - competing on a global scale

Kate Galpin, ASX 

More than 270 international companies are leveraging an ASX listing to support and fund their growth ambitions. The ASX’s Kate Galpin writes about how listing on ASX provides access to public-market investor capital at an earlier stage than on other major international exchanges. 

VIDEO INTERVIEW | ON THE BOARD

11 MAY 2022 

Getting to know Australian Clinical Labs (ASX:ACL)  

Interview with Melinda McGrath

Melinda McGrath, CEO of pathology provider, Australian Clinical Labs, spoke to On the Board about the company’s listing journey and how it has enabled them to get more operating leverage and gain market advantage. [viewing time 7:28]

COMPANY PROFILE | ON THE BOARD 

11 MAY 2021

Microba Life Sciences trusts gut instinct with IPO 

Interview with Dr. Luke Reid, CEO 

We spoke to Dr Luke Reid about how an ASX listing has helped this biotech accelerate the commercialisation of it microbiome research in global markets.  

COMPANY PROFILE | ON THE BOARD 

11 MAY 2022 

BioTechNZ builds on New Zealand’s biotechnology strengths 

Interview with Dr. Zahra Champion, Executive Director

BioTech New Zealand is helping to build a vibrant ecosystem for biotech companies in NZ that better connects biotech researchers to companies across industry, and to global capital markets. 

INSIGHTS | MARKETS

New frontiers in financial markets

This is a time of evolution and change in the financial sector, both in Australia and globally.

INSIGHTS | ASX DATA

Data Insights 2022

ASX Information Services

Key indicators of activity in the Australian financial market over time.

BLOG SERIES | BLOCKCHAIN WEEK

4 APRIL 2022

Blockchain Trends 2022

ASX DLT Solutions

Paul Stonham, General Manager, DLT Solutions at ASX shares his key learnings from Blockchain Week through a series of blogs on the major trends for the industry.

INSIGHT REPORT | CORPORATE ACTIONS

17 FEBRUARY 2022

Corporate Actions in Australia: The Case for Transformation

ASX Information Services

Insights from a benchmarking program on corporate actions processing in Australia paint a clear picture of the industry landscape and provide a compelling business case for change.

ARTICLE | OTC MARKETS UPDATE

8 DECEMBER 2021

Uncleared margin and central clearing access

ASX and KangaNews

The introduction of uncleared-margin rules for OTC derivatives in Australia is leading market participants to consider central-clearing solutions.

ARTICLE | OTC MARKETS UPDATE

11 OCTOBER 2021

The road to multiple clearers

ASX

Do I need multiple clearers?  This is a key question for many buy-side firms when commencing or expanding usage of centrally cleared OTC derivatives.

ARTICLE | OTC MARKETS UPDATE

18 AUGUST 2021

Improving counterparty access and liquidity

ASX

With trading continuing to shift from a non-cleared to cleared basis, access to central clearing enables firms to improve or retain desired levels of access to counterparties and liquidity.

WHITEPAPER | MARKET INSIGHTS CONNECTIVITY

15 JULY 2021

Special report: Ecosystems for Success

ASX Connectivity Services

A whitepaper discussing the importance of connectivity in capital market ecosystems, taking a closer look at exchange colocation facilities.

ARTICLE | MARKET INSIGHTS OTC

06 JULY 2021

Strategies for Uncleared Margin Rules

ASX

OTC and futures clearing provide a key risk management tool when managing derivatives trading. We provide insight into the implementation of the uncleared margin rules in Australia and review some of the strategies firms are putting in place.